Abstract
Efficient clearance of virus infections depends on the nature of the host response raised by the infected organism. A proinflammatory cell-mediated immune response is important for elimination of many viruses, including herpesviruses. Macrophages are intimately involved in generation of a proinflammatory response, the initiation of which involves activation of the transcription factor NF-kappaB. However, the mechanisms of HSV-induced NF-kappaB activation are poorly understood. In this study we demonstrate that activation of NF-kappaB by HSV in macrophages is dependent on a functional viral genome and proceeds through a mechanism involving the cellular IkappaB kinase, as well as the upstream kinases TGF-beta-activated kinase 1, mitogen-activated kinase/extracellular signal-regulated kinase kinase 1, and possibly NF-kappaB-inducing kinase. Furthermore, we show that HSV triggers NF-kappaB activation by a signaling pathway involving oxidative stress in mitochondria and intracellular calcium, because specific inhibition of mitochondria-derived reactive oxygen intermediates, as well as mitochondrial calcium channels, prevented NF-kappaB activation. Together, these results point to mitochondria as cellular checkpoints able to initiate NF-kappaB activation after virus infection and also show that the cellular NF-kappaB-regulating kinases IkappaB kinase, TGF-beta-activated kinase 1, mitogen-activated kinase/extracellular signal-regulated kinase kinase 1, and possibly NF-kappaB-inducing kinase, are essential components in the HSV-induced signaling pathway.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Active Transport, Cell Nucleus / genetics
-
Animals
-
Antiviral Agents / pharmacology
-
Calcium Signaling / physiology*
-
Calcium-Calmodulin-Dependent Protein Kinases / physiology
-
Cell Line
-
Cell Nucleus / genetics
-
Cell Nucleus / metabolism
-
Chemokine CCL5 / biosynthesis
-
Chemokine CCL5 / genetics
-
Enzyme Activation
-
Female
-
Gene Expression Regulation, Viral / drug effects
-
Genes, Immediate-Early / drug effects
-
I-kappa B Kinase
-
Inflammation Mediators / metabolism
-
Intracellular Fluid / metabolism
-
Lipopolysaccharides / antagonists & inhibitors
-
Lipopolysaccharides / pharmacology
-
MAP Kinase Kinase Kinase 1*
-
MAP Kinase Kinase Kinases / biosynthesis
-
MAP Kinase Kinase Kinases / genetics
-
MAP Kinase Kinase Kinases / metabolism
-
MAP Kinase Kinase Kinases / physiology*
-
Macrophages, Peritoneal / drug effects
-
Macrophages, Peritoneal / enzymology
-
Macrophages, Peritoneal / metabolism*
-
Macrophages, Peritoneal / virology*
-
Mice
-
Mice, Inbred C57BL
-
Mitochondria / metabolism
-
Mitochondria / physiology*
-
Mitochondria / virology
-
NF-kappa B / antagonists & inhibitors
-
NF-kappa B / metabolism*
-
NF-kappa B / physiology
-
NF-kappa B p50 Subunit
-
NF-kappaB-Inducing Kinase
-
Oxidative Stress*
-
Protein Serine-Threonine Kinases / biosynthesis
-
Protein Serine-Threonine Kinases / genetics
-
Protein Serine-Threonine Kinases / metabolism
-
Protein Serine-Threonine Kinases / physiology*
-
Reactive Oxygen Species / metabolism
-
Simplexvirus / drug effects
-
Simplexvirus / genetics
-
Simplexvirus / physiology
-
Transcription Factor RelA
-
Transfection
-
Virus Replication / drug effects
Substances
-
Antiviral Agents
-
Chemokine CCL5
-
Inflammation Mediators
-
Lipopolysaccharides
-
NF-kappa B
-
NF-kappa B p50 Subunit
-
Reactive Oxygen Species
-
Transcription Factor RelA
-
Protein Serine-Threonine Kinases
-
Chuk protein, mouse
-
I-kappa B Kinase
-
Ikbkb protein, mouse
-
Ikbke protein, mouse
-
Calcium-Calmodulin-Dependent Protein Kinases
-
MAP Kinase Kinase Kinase 1
-
MAP Kinase Kinase Kinases
-
MAP kinase kinase kinase 7
-
Map3k1 protein, mouse